Guide to Clinical Evaluation: Clinical Evaluation in Context

Dr Peter Boxall

In the ever-evolving world of medical device regulation, clinical evaluation is often seen as a standalone exercise. Yet, for manufacturers striving for MDR compliance, it is far more than that; it is the linchpin that connects multiple components of your technical documentation.

In this second episode of our Guide to Clinical Evaluation video series, we explore how clinical evaluation fits into the broader technical file, and how other sections of the file both inform and are informed by it.

At its core, a clinical evaluation demonstrates that a device is safe and effective for its intended purpose. But achieving this requires more than simply compiling clinical studies; it involves integrating insights from across the technical file. Key inputs include intended purpose, clinical evidence, general safety and performance requirements (GSPRs), pre-clinical testing, risk management file, and post-market surveillance.

The beauty of a robust clinical evaluation lies in its dual role: not only does it synthesise inputs from across the technical file, but its outputs also influence other regulatory processes. Clinical findings can prompt updates to the risk management file, inform labelling, or trigger modifications to post-market surveillance plans.

When viewed in isolation, clinical evaluation may appear as a single chapter in the technical file. In reality, it is a central hub, a living document that both draws from and feeds into the broader technical file. By leveraging other components of the technical file, manufacturers can create a clinical evaluation that is not only compliant with MDR but also genuinely insightful, guiding safer and more effective use of medical devices in the real world.

A Proven Framework for Success

At Mantra Systems, we know what success looks like. Our approach to clinical evaluation is built on experience: over 300 successful evaluations conducted under MDR. This track record reflects not just regulatory knowledge, but also a deep commitment to patient safety, clinical relevance, and quality of evidence.

Through this series, we’ll share that expertise with you, helping you avoid the pitfalls we see most often and giving you a clear pathway to stronger, more resilient submissions.

If you missed Episode 1: What is Clinical Evaluation? Catch up here.

Subscribe to our newsletter to keep up with the full five-part series on mastering MDR clinical evaluation, including:

  1. What is clinical evaluation?
  2. Clinical evaluation in context
  3. The State-of-the-Art (SOTA) review – core of a successful submission
  4. The CEP and CER
  5. Clinical evaluation pitfalls and useful resources

Related articles

  1. Collage art showing a pair of binoculars, an analogy for surveillance.

    How EU MDR Post Market Surveillance differs from FDA post-market expectations

    We compare manufacturer-specific post-market obligations across both regulatory systems.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  2. An arrow arcs from the US over to Europe.

    How EU device classification differs from the US - Are you Prepared?

    Did you know an FDA Class II medical device could be immediately considered as a high-risk Class III device under European Union regulations?

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  3. A magnifying glass inspecting a number of wooden cubes with question marks upon them laid upon a blue table. The wooden cube under the magnifying glass has a lightbulb painted on it.

    Fixing the MDR and IVDR? The Commission’s Proposed Amendments and What They Mean for Manufacturers

    Exploring the key elements of this proposal.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  4. An illustration showing a business woman pole-vaulting across a ravine.

    Eliminating the Top 5 Notified Body Gaps in Clinical Evaluation Through Pre-Submission Review

    From insufficient clinical evidence to Post-Market issues - we guide you past common NB deficiencies.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  5. Two arms point at a sign and hold a question mark, in an abstract pop-art style.

    Regulatory Reset? The EU’s Proposed Changes to MDR and IVDR Explained

    Changes published in December 2025 aim to streamline EU medical device and in vitro diagnostics. We explain who is impacted and how.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  6. A pair of glasses rests on an eye test chart.

    Did You Know Your Glasses Were a Medical Device? A Regulatory Guide for Manufacturers

    The importance of correct classification and our recommended path to avoid common ophthalmic device 'gotchas'.

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  7. A man sitting whilst a nurse prepares his arm for an injection.

    Why Clinical Trial Design Should Begin at the Earliest Stages of Medical Device Development

    In this guest post from our partners at Franklyn Health, they explore the benefits of a well-planned approach.

    Rob Bedford Rob Bedford Head of Clinical Operations at Franklyn Health
  8. A precariously balanced pile of ping-pong balls and wooden bars.

    The Shift from MDD to MDR: Key Differences in Demonstrating Equivalence

    This transition has demanded that device safety must be demonstrated with more evidence. We offer tips for winning equivalence claims.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  9. Holding up the Mantra Systems sign with Shanghai as a backdrop.

    2025: A year in review

    Our CEO takes a seasonal look back at our year in medical device regulation. Plus a peek at some of our offerings planned for 2026.

    Paul Hercock Paul Hercock Chief Executive Officer
  10. A pen and notepad, resting on a laptop.

    Periodic Safety Update Report: Requirements under EU MDR

    Post-Market Surveillance has become more stringent. We help you to understand what manufacturers need to consider.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  11. An EU flag on a pole flies between two US flags against a blue sky.

    Webinar: From USA to Europe - Accelerating Your Path to the Medical Device Market

    We showed you how to quickly transform your U.S. regulatory work into a compliant EU MDR submission.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  12. A poster frame for our Clinical Evaluation video series featuring Paul Hercock.

    Guide to Clinical Evaluation: Common Pitfalls & Useful Resources

    Part 5 - In the final video from this series, we explore five major pitfalls that often derail clinical evaluations.

    Paul Hercock Paul Hercock Chief Executive Officer

More articles

Need help producing compliant CEPs & CERs? We are offering FREE CEPs to 5 qualifying applicants per week

Get your free CEP